Comparison of the impact of chronic corticosteroid therapy on critical care outcomes of COVID-19 patients with and without history of chronic liver disease
Abstract There is a paucity of studies investigating the impact of chronic corticosteroid use for coexisting conditions in patients with Coronavirus Disease 2019 (COVID-19). Additionally, the information regarding the impact of chronic liver disease (CLD) on COVID-19 outcomes is evolving. Our study...
Guardado en:
Autores principales: | Hammad Liaquat, Brittney Shupp, Samantha Rollins, Yecheskel Schneider, Ayaz Matin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/40ee2b3596364b299ad14193c36c6616 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Evaluating the association of osteoporosis with inhaled corticosteroid use in chronic obstructive pulmonary disease in Taiwan
por: Kai-Lin Chiu, et al.
Publicado: (2021) -
Gait Asymmetry Comparison between Subjects with and without Nonspecific Chronic Low Back Pain
por: Dongchul Lee, et al.
Publicado: (2021) -
Polymyalgia rheumatica: observations of disease evolution without corticosteroid treatment
por: Brawer AE
Publicado: (2016) -
Autonomic dysfunction in chronic liver disease
por: Frith J, et al.
Publicado: (2011) -
The pathophysiology of thrombocytopenia in chronic liver disease
por: Mitchell O, et al.
Publicado: (2016)